Wilfried E E Eberhardt

Wilfried E E Eberhardt

UNVERIFIED PROFILE

Are you Wilfried E E Eberhardt?   Register this Author

Register author
Wilfried E E Eberhardt

Wilfried E E Eberhardt

Publications by authors named "Wilfried E E Eberhardt"

Are you Wilfried E E Eberhardt?   Register this Author

36Publications

1219Reads

11Profile Views

Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.

Clin Lung Cancer 2018 11 22;19(6):e879-e884. Epub 2018 Aug 22.

Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.08.016DOI Listing
November 2018

Brain metastases in ALK-positive NSCLC - time to adjust current treatment algorithms.

Oncotarget 2018 Oct 12;9(80):35181-35194. Epub 2018 Oct 12.

Department of Medical Oncology, West German Cancer Center, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/26073
Publisher Site
http://dx.doi.org/10.18632/oncotarget.26073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205553PMC
October 2018

Clinical implications of the innovations in the primary tumour and metastasis of the 8 edition of the TNM classification for lung cancer.

J Thorac Dis 2018 Aug;10(Suppl 22):S2682-S2685

Department of Medical Oncology, West German Cancer Centre, Ruhrlandklinik, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.03.100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178296PMC
August 2018

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study.

BMC Cancer 2018 Feb 5;18(1):135. Epub 2018 Feb 5.

Internistische Onkologie der Thoraxtumoren, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4032-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799904PMC
February 2018

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

J Clin Oncol 2017 Dec 12;35(35):3924-3933. Epub 2017 Oct 12.

Leora Horn, Vanderbilt-Ingram Cancer Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Everett E. Vokes, University of Chicago, Chicago, IL; Esther Holgado, Hospital De Madrid, Norte Sanchinarro, Madrid; Enriqueta Felip, Hospital Universitari Vall d'Hebron, Barcelona; Luis Paz-Ares, Hospital Universitario Virgen Del Rocio, Seville, Spain; Neal Ready, Duke University Medical Center, Durham, NC; Martin Steins, Thoraxklinik-Heidelberg gGmbH, Heidelberg; Martin Kohlhäeufl, Robert-Bosch-Krankenhaus, Stuttgart; Martin Reck, LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Wilfried E.E. Eberhardt, University Hospital and Ruhrlandclinic, University of Duisburg-Essen, Essen, Germany; Elena Poddubskaya, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Adam Pluzanski, Centrum Onkologii-Instytut Im. Marii Sklodowskiej-Curie, Warsaw, Poland; Karen L. Reckamp, City of Hope, Duarte, CA; Marco A. Burgio and Lucio Crinò, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Scientifico Romagnolo Per lo Studio e la Cura dei Tumori, Meldola, Italy; David Waterhouse, Oncology Hematology Care (OHC)/US Oncology, Cincinnati, OH; Fabrice Barlesi, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Marseille; Jérôme Fayette, Léon Bérard, Lyon, France; Scott Antonia, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Oscar Arrieta, Instituto Nacional De Cancerologia, Mexico City, Mexico; Naiyer Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; William J. Geese, Ang Li, Anne Blackwood-Chirchir, and Diane Healey, Bristol-Myers Squibb, Princeton, NJ; and Julie Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.3062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075826PMC
December 2017

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer.

J Thorac Oncol 2017 01 27;12(1):54-64. Epub 2016 Aug 27.

Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Thoracic Oncology, West German Lung Center, Ruhrlandklinik, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.08.137DOI Listing
January 2017

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.

J Clin Oncol 2015 Dec 31;33(34):4007-14. Epub 2015 Aug 31.

Karen Kelly, University of California, Davis, Comprehensive Cancer Center, Sacramento, CA; Nasser K. Altorki, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY; Wilfried E.E. Eberhardt, University Hospital Essen, Essen, Germany; Mary E.R. O'Brien, Royal Marsden Hospital, London, United Kingdom; David R. Spigel, Sarah Cannon Research Institute, Nashville, TN; Lucio Crinò, Ospedale S. Maria della Misericordia, Perugia, Italy; Chun-Ming Tsai, Taipei General Hospital and National Yang-Ming University, Taipei, Taiwan; Joo-Hang Kim, Yonsei University Health System, Seoul; Eun Kyung Cho, Gachon University, Incheon, Korea; Philip C. Hoffman, The University of Chicago Medical Center, Chicago; Jiuzhou Wang and Margaret A. Foley, Astellas Pharma, Northbrook, IL; Sergey V. Orlov, I.P. Pavlov Medical University, St Petersburg, Russia; Piotr Serwatowski, Specjalistyczny Szpital, Sokolowskiego, Szczecin, Poland; Julie D. Horan, Novella Clinical, Boulder, CO; and Frances A. Shepherd, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.61
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.8918
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.8918DOI Listing
December 2015

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.

J Thorac Oncol 2015 Nov;10(11):1515-22

*Department of Medical Oncology, West German Cancer Centre, Ruhrlandklinik, University Hospital Essen, University Duisburg-Essen, Essen, Germany; †Cancer Research And Biostatistics, Seattle, Washington; ‡Kyorin University Hospital, Tokyo, Japan; §Department of Thoracic and Cardiovascular Surgery, Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea; ‖Sinai Grace Hospital, Detroit, Michigan; ¶Royal Brompton Hospital and Imperial College, London, United Kingdom; #Department of Thoracic Surgery, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain; and **CIBERES Lung Cancer Group, Terrassa, Barcelona, Spain; and ††Members of International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board, and Participating Institutions are listed in Appendix.

View Article

Download full-text PDF

Source
http://www.pneumonologia.gr/articlefiles/IASLC%20NSCLC.pdf
Web Search
http://www.slpneumo.lu/download/hot-topics/NewLymphNodeMap-N
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S155608641535063
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000673DOI Listing
November 2015

Multimodal treatment of non-small-cell lung cancer.

Lancet 2015 Sep 11;386(9998):1018-20. Epub 2015 Aug 11.

Department of Radiation Oncology, West German Tumour Centre, University Hospital Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)61083-2DOI Listing
September 2015

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Jul 31;373(2):123-35. Epub 2015 May 31.

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.B.); the City of Hope Comprehensive Cancer Center, Duarte, CA (K.L.R.); the Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam (P.B.), Erasmus MC Cancer Institute, Rotterdam (J.G.A.), and Ziekenhuis Amphia, Breda (J.G.A.) - all in the Netherlands; the University Hospital of Perugia, Perugia (L.C.), and the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.) - both in Italy; the Department of Medical Oncology, West German Cancer Center, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen (W.E.E.E.), the Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.), and the LungenClinic Grosshansdorf, Grosshansdorf (M.R.) - all in Germany; the N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); the H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.A.); the Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland (A.P.); the University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); the Hospital Madrid Norte Sanchinarro (E.H.), the Hospital Universitario Fundación Jiménez Díaz, Madrid (M.D.), and the Hospital Universitario Virgen Del Rocío, Seville (L.P.-A.) - all in Spain; Oncology Hematology Care, Cincinnati (D.W.); the Duke University Medical Center, Durham, NC (N.R.); Massachusetts General Hospital, Boston (J.G.); Centro Internacional de Estudios Clinicos, Santiago, Chile (O.A.F.); Nemocnice Na Bulovce, Prague, Czech Republic (L.H.); Bristol-Myers Squibb, Princeton, NJ (C.B., C.T.H., B.L.); and the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681400PMC
July 2015

Benefits and risks of lung cancer screening.

Oncol Res Treat 2014 29;37 Suppl 3:58-66. Epub 2014 Aug 29.

1. Medizinische Klinik, Klinik für Pneumologie, Schlaf- und Beatmungsmedizin, HELIOS Klinikum Erfurt GmbH, Erfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000365234DOI Listing
May 2015

Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements.

Curr Opin Oncol 2014 Mar;26(2):171-81

Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, North Rhine-Westphalia, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000053DOI Listing
March 2014

Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours.

Invest New Drugs 2012 Oct 12;30(5):1962-71. Epub 2011 Oct 12.

Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisbug-Essen Essen, Hufelandstr. 55, 45122, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-011-9754-xDOI Listing
October 2012

Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell lines.

Int J Radiat Oncol Biol Phys 2012 Oct 28;84(2):492-9. Epub 2012 Feb 28.

Department of Radiotherapy, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.12.021DOI Listing
October 2012

Very late and isolated leptomeningeal relapse of a pulmonary adenocarcinoma presenting as dementia.

Onkologie 2011 17;34(6):316-20. Epub 2011 May 17.

Department of Medicine (Cancer Research), West German Cancer Center, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000328765DOI Listing
November 2011

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.

J Thorac Cardiovasc Surg 2010 Jun 24;139(6):1424-30. Epub 2010 Apr 24.

Division of Thoracic Surgery, University Hospital Zurich, CH-8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002252231000223
Publisher Site
http://dx.doi.org/10.1016/j.jtcvs.2010.02.039DOI Listing
June 2010

Chemotherapy in stage III non-small cell lung cancer.

Eur J Cancer 2009 Sep;45 Suppl 1:126-36

Department of Medicine (Cancer Research), West German Tumor Centre, University Hospital of University Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0959-8049(09)70024-3DOI Listing
September 2009

Surgery in stage III non-small-cell lung cancer.

Lancet 2009 Aug 24;374(9687):359-60. Epub 2009 Jul 24.

Department of Medicine (Cancer Research), West German Tumour Centre, University Hospital Essen of the University Duisburg-Essen, 45122 Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(09)61026-6DOI Listing
August 2009

The role of surgery in stage IIIA non-small cell lung cancer.

Hematol Oncol Clin North Am 2005 Apr;19(2):303-19, vi-vii

Department of Internal Medicine (Cancer Research), West German Cancer Centre Essen, Universitätsklinikum of the University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2005.02.002DOI Listing
April 2005